‘Morbius’: Sony Sinking Teeth This Weekend Into Deeper Part Of The Marvel Genre Canon – Box Office Preview

Breaking News, Film News, Morbius, Sony

Sony is further exploiting its end of the Marvel franchise this weekend with the long-delayed Jared Leto dark hero title MorbiusBooked at 4,200 locations, the Marvel vampire protagonist feature is eyeing a studio expected opening of $33M, but could get as high as $40M-$50M.

Reviews haven’t registered yet on Rotten Tomatoes, however, Sony has bested critics before with Venom which after a 30% RT score opened to $80.2M; at one point the biggest October record.

The movie, which at one point in 2020 was scheduled to come out before Venom: Let There Be Carnage and Spider-Man: No Way Home on July 3, will no doubt keep the good vibe wave of box office openings going as moviegoers became more comfortable during the pandemic. Last weekend, Paramount brought the cautious older female demographic back with Sandra Bullock-Channing Tatum’s romantic comedy adventure The Lost City which debuted to $30.4M.

The Daniel Espinosa directed, Matt Sazama and Burk Sharpless scripted movie is Sony’s foray into the deeper part of its Marvel licensed universe, particularly genre type films and at a lower budget, this one being an estimated $75M before P&A. It’s been a while since we’ve had a Marvel genre movie, i.e. the late ’90s Blade franchise being one of the last ones. While Morbius is known to be a villain of Spider-Man’s, the film is a standalone origin story about biochemist Michael Morbius, who tries to cure himself of a rare blood disease, but winds up infecting himself with a form of vampirism instead.

Products You May Like

Articles You May Like

Glorilla Performs “Tomorrow 2” With Cardi B at the 2022 American Music Awards: Watch
Travis Scott, Skepta to Headline Mirror Mirror Festival Honoring Virgil Abloh
Take Two Weekend Preview: Deadline Critics On ‘Glass Onion’, ‘Devotion’ & ‘The Son’
Knives Out’s Rian Johnson Thought Everyone Knew Glass Onion Was A Beatles Reference. He Was Wrong
U.S. Senators to Investigate Ticketmaster’s Dominance Over Concert Ticket Sales

Leave a Reply

Your email address will not be published.